Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent
In the United States, duloxetine has been approved for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and fibromyalgia in the adult population. Data regarding the use of duloxetine in the pediatric population, however, are very limited. Femoral nerve injury is a rar...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2011/164984 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552770058584064 |
|---|---|
| author | Ludmyla Kachko Shiri Ben Ami Alon Liberman Einat Birk Sefi Kronenberg |
| author_facet | Ludmyla Kachko Shiri Ben Ami Alon Liberman Einat Birk Sefi Kronenberg |
| author_sort | Ludmyla Kachko |
| collection | DOAJ |
| description | In the United States, duloxetine has been approved for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and fibromyalgia in the adult population. Data regarding the use of duloxetine in the pediatric population, however, are very limited. Femoral nerve injury is a rare complication of cardiac catheterization. In the case described, duloxetine contributed to a successful multimodal treatment program for peripheral neuropathic pain due to femoral neuropathy in an adolescent with ‘reactive depression’ and conversion symptoms. To the best of the authors’ knowledge, the present article is only the third such report on this dual use of duloxetine in children and adolescents, and the first report of such treatment following femoral neuropathy induced by cardiac catheterization. |
| format | Article |
| id | doaj-art-53eae7dac598447a837101a81de220e9 |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-53eae7dac598447a837101a81de220e92025-02-03T05:57:45ZengWileyPain Research and Management1203-67652011-01-0116645745910.1155/2011/164984Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an AdolescentLudmyla Kachko0Shiri Ben Ami1Alon Liberman2Einat Birk3Sefi Kronenberg4Chronic Pain Clinic, Pain Treatment Service, Tel Aviv University, Tel Aviv, IsraelChronic Pain Clinic, Pain Treatment Service, Tel Aviv University, Tel Aviv, IsraelChronic Pain Clinic, Pain Treatment Service, Tel Aviv University, Tel Aviv, IsraelPediatric Heart Institute, Tel Aviv University, Tel Aviv, IsraelDepartment of Psychological Medicine, Tel Aviv University, Tel Aviv, IsraelIn the United States, duloxetine has been approved for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and fibromyalgia in the adult population. Data regarding the use of duloxetine in the pediatric population, however, are very limited. Femoral nerve injury is a rare complication of cardiac catheterization. In the case described, duloxetine contributed to a successful multimodal treatment program for peripheral neuropathic pain due to femoral neuropathy in an adolescent with ‘reactive depression’ and conversion symptoms. To the best of the authors’ knowledge, the present article is only the third such report on this dual use of duloxetine in children and adolescents, and the first report of such treatment following femoral neuropathy induced by cardiac catheterization.http://dx.doi.org/10.1155/2011/164984 |
| spellingShingle | Ludmyla Kachko Shiri Ben Ami Alon Liberman Einat Birk Sefi Kronenberg Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent Pain Research and Management |
| title | Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent |
| title_full | Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent |
| title_fullStr | Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent |
| title_full_unstemmed | Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent |
| title_short | Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent |
| title_sort | duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid reactive depression in an adolescent |
| url | http://dx.doi.org/10.1155/2011/164984 |
| work_keys_str_mv | AT ludmylakachko duloxetinecontributingtoasuccessfulmultimodaltreatmentprogramforperipheralfemoralneuropathyandcomorbidreactivedepressioninanadolescent AT shiribenami duloxetinecontributingtoasuccessfulmultimodaltreatmentprogramforperipheralfemoralneuropathyandcomorbidreactivedepressioninanadolescent AT alonliberman duloxetinecontributingtoasuccessfulmultimodaltreatmentprogramforperipheralfemoralneuropathyandcomorbidreactivedepressioninanadolescent AT einatbirk duloxetinecontributingtoasuccessfulmultimodaltreatmentprogramforperipheralfemoralneuropathyandcomorbidreactivedepressioninanadolescent AT sefikronenberg duloxetinecontributingtoasuccessfulmultimodaltreatmentprogramforperipheralfemoralneuropathyandcomorbidreactivedepressioninanadolescent |